𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization and localization of mitochondrial oligopeptidase (MOP) (EC 3.4.24.16) activity in the human cervical adenocarcinoma cell line HeLa

✍ Scribed by Darren R. Krause; Terrence J. Piva; Simone B. Brown; Kay A.O. Ellem


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
129 KB
Volume
66
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


In this study we describe the partial purification and characterization of the HeLa cell oligopeptidase M or endopeptidase 3.4.24.16. The HeLa enzyme was isolated initially by its ability to hydrolyse a nonapeptide substrate (P9) which was cognate to the N-terminal cleavage site of preproTGFa. The enzyme was shown to be a metalloprotease as it was inhibited by Zn 21 -chelating agents and DTT, and had an approximate molecular weight of 55-63 kD determined by gel filtration. Neurotensin, dynorphin A 1-17 and GnRH 1-9 were rapidly degraded by the enzyme while GnRH 1-10 and somatostatin were not. Neurotensin was cleaved at the Pro 10 -Tyr 11 bond, leading to the formation of neurotensin (1-10) and neurotensin (11-13). The K m for neurotensin cleavage was 7 µM and the K i for the specific 24.16 dipeptide inhibitor (Pro-Ile) was 140 µM which were similar to those observed from the human brain enzyme [Vincent et al. (1996): Brain Res 709:51-58].

Through the use of specific antibodies, the purified HeLa enzyme was shown to be oligopeptidase M. This enzyme and its closely related family member thimet oligopeptidase were shown to co-elute during the isolation procedure but were finally separated using a MonoQ column. Oligopeptidase M is located mainly in mitochondria though it was detected on the plasma membrane in an inactive form. The results obtained demonstrate the first recorded instance of this enzyme in human tissue cultured cells, and raise the issue of its function therein.


📜 SIMILAR VOLUMES